Invention Grant
US08728527B2 Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
有权
具有降低奥斯特瓦尔德熟化的水不溶性药物的固体纳米颗粒制剂
- Patent Title: Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
- Patent Title (中): 具有降低奥斯特瓦尔德熟化的水不溶性药物的固体纳米颗粒制剂
-
Application No.: US12309581Application Date: 2007-07-24
-
Publication No.: US08728527B2Publication Date: 2014-05-20
- Inventor: Chandra Ulagaraj Singh
- Applicant: Chandra Ulagaraj Singh
- Applicant Address: US TX San Antonio
- Assignee: Luminus Biosciences, Inc.
- Current Assignee: Luminus Biosciences, Inc.
- Current Assignee Address: US TX San Antonio
- Agency: Nevrivy Patent Law Group P.L.L.C.
- International Application: PCT/US2007/016599 WO 20070724
- International Announcement: WO2008/013785 WO 20080131
- Main IPC: A61K9/38
- IPC: A61K9/38
Abstract:
The present invention belongs to the fields of pharmacology, medicine and medicinal chemistry. The present invention provides novel pharmaceutical compositions composed of solid nanoparticles dispersed in aqueous medium of substantially water insoluble pharmaceutical substances such as docetaxel with reduced Ostwald ripening.
Public/Granted literature
Information query
